Menu
ÚHKT

Impaktované publikace

[1]

Belickova, M.; Vesela, J.; Jonasova, A.; Pejsova, B.; Votavova, H.; Dostalova Merkerova, M.; Zemanova, Z.; Brezinova, J.; Mikulenkova, D.; Lauermannova, M.; Valka, J.; Michalova, K.; Neuwirtova, R.; Cermak, J.

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes

[rok vydání 2016, impact factor 5.168 ]

[2]

Belickova, M.; Merkerova, M.D.; Stara, E.; Vesela, J.; Sponerova, D.; Mikulenkova, D.; Brdicka, R.; Neuwirtova, R.; Jonasova, A.; Cermak, J.

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

[rok vydání 2013, impact factor 4.933 ]

[3]

Burda, P.; Curik, N.; Kokavec, J.; Basova, P.; Mikulenkova, D.; Skoultchi, A.I.; Zavadil, J.;Stopka, T.

PU.1 activation relieves GATA-1–mediated repression of Cebpa and Cbfb during leukemia differentiation

[rok vydání 2010, impact factor 4.162]

[4]

de Swart, L.; Smith, A.; MacKenzie, M.; Symeonidis, A.; Neukirchen, J.; Mikulenková, D.; Vallespi, T.; Zini, G.; Paszkowska-Kowalewska, M.; Kruger, A.; Saft, L.; Fenaux, P.; Bowen, D.; Hellström-Lindberg, E.; Čermák, J.; Stauder, R.; Tatic, A.; Holm, M.S.; Malcovati, L.; Madry, K.; Droste, J.; Blijlevens, N.; de Witte, T.; Germing, U.

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

[rok vydání 2017, impact factor 2.845 ]

[5]

Jonasova, A.; Bokorova, R.; Polak, J.; Vostry, M.; Kostecka, A.; Hajkova, H.; Neuwirtova, R.; Siskova, M.; Sponerova, D.; Cermak, J.; Mikulenkova, D.; Cervinek, L.; Brezinova, J.; Michalova, K.; Fuchs, O.

High level of full length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide

[rok vydání 2014, impact factor 2.544 ]

[6]

Cermak, J.; Kacirkova, P.; Mikulenkova, D.; Michalova, K.

Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts

[rok vydání 2009, impact factor 2.358]

[7]

Provaznikova, D.; Geierova, V.; Kumstyrova; Kotlin, R.; Mikulenkova, D.; Zurkova, K.; Matoska, V.; Hrachovinova, I.; Rittich, S.

Clinical manifestation and molecular genetic characterization of MYH9 disorders

[rok vydání 2009, impact factor 2.272]

[8]

Smetana, K.; Jirásková, I.; Mikulenková, D.; Klamová, H.

Nucleolar and cytoplasmic RNA density-concentration in leukemia granulocytic progenitors in human bone marrow biopsies: a short cytochemical note

[rok vydání 2009, impact factor 1.829 ]

[9]

Smetana, K.; Mikulenková, D.; Klamová, H.

The heterochromatin condensation state in central nuclear regions of individual granulocytes

[rok vydání 2013, impact factor 1.775 ]

[10]

Smetana, K.; Klamová, H.; Jirásková, I.; Mikulenková, D.

A short cytochemical note on the nucleolar and cytoplasmic RNA concentration in differentiating cells represented by human erythroblasts

[rok vydání 2009, impact factor 1.735]

[11]

Smetana, K.; Klamová, H.; Mikulenková, D.

To the approximate size of the nuclear region occupied by nucleolar bodies during cell differentiation and maturation using the human leukemic granulocytic lineage as a convenient model

[rok vydání 2019, impact factor 1.655 ]

[12]

Polák, J.; Hájková, H.; Haškovec, C.; Čechová, H.; Marinov, I.; Mikulenková, D.; Marková, J.; Vítek, A.; Válková, V.

Quantitative monitoring of WT-1 expression in peripheral blood before and after allogenenic stem cell transplantation for acute myeloid leukemia: a useful tool for early detection of minimal residual disease

[rok vydání 2012, impact factor 1.642 ]

[13]

Smetana, K.; Klamová, H.; Jirásková, I.; Mikulenková, D.

Perinucleolar heterochromatin during the cell differentiation using human leukemic neutrophils as a convenient model

[rok vydání 2015, impact factor 1.509 ]

[14]

Schwarz, J.; Mikulenková, D.; Čermáková, K.; Polanská, V.; Michalová, K.; Marinov, I.; Campr, V.; Ransdorfová, Š.; Marková, J.; Pavlištová, L.; Březinová, J.; Sajdová, J.; Šponerová, D.; Volková, Z.; Benešová, K.; Čermák, J.; Vítek, A.; Cetkovský, P.

Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia : correlations with IgVH gene mutational status and other prognostic markers

[rok vydání 2006, impact factor 1.247]

[15]

Smetana, K.; Klamova, H.; Mikulenkova, D.; Pluskalova, M.; Hrkal, Z.

On the nucleolar size and density in human early granulocytic progenitors, myeloblasts

[rok vydání 2006, impact factor 1.191]

[16]

Smetana, K.; Mikulenková, D.; Klamová, H.

Heterochromatin density (condensation) during cell differentiation and maturation using the human granulocytic lineage of chronic myeloid leukaemia as a convenient model

[rok vydání 2011, impact factor 1.151]

[17]

Smetana, K.; Mikulenková, D.; Klamová, H.

Morphometric and densitometric analysis of heterochromatin during cell differentiation using the leukaemic granulocytic lineage as a convenient model

[rok vydání 2017, impact factor 1.044]

[18]

Smetana, K.; Klamová, H.; Jirásková, I.; Mikulenková, D.; Zápotocký, M.; Hrkal, Z.

The DNA chromatin condensation expressed by the image optical density of chromosomes and chromatin in proliferating single human leukemic granulocytic progenitors

[rok vydání 2012, impact factor 0.978 ]

[19]

Smetana, K.; Klamová, H.; Mikulenková, D.

Dominant nucleolus in the progenitor cell using human erythroid cell lineage as a model: a morphological and cytochemical note

[rok vydání 2020, impact factor 0.691]

[20]

Smetana, K.; Mikulenková, D.; Jirásková, I.; Klamová, H.

A karyometric note on nucleoli in human early granulocytic precursors

[rok vydání 2007, impact factor 0.387]